Skip to content
Does Spravato require patients to be prescribed an antidepressant? episode artwork

Mar 20, 2019 10 min

Does Spravato require patients to be prescribed an antidepressant?

from Ketamine Wellness Centers Podcast Hosted by Ketamine Wellness Centers

As the P.R. machine kicks into gear to support the launch of Spravato/Esketamine, the first FDA approved Ketamine-derived treatment, Kevin Nicholson (President, CEO of Ketamine Wellness Centers) digs into the details that tend to receive less attention. This episode is about Treatment Resistant Depression and the requirements of Spravato, as such. We touch on: - The clinical definition of Treatment Resistant Depression - What to do about co-occurring conditions such as anxiety, suicidal ideation, ocd, etc? - Does Spravato require patients to be prescribed to an antidepressant to qualify for using it? - Is Spravato utilizing the full potential of Ketamine to treat Depression?

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Does Spravato require patients to be prescribed an antidepressant?

0:00 10:42

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of Ketamine Wellness Centers Podcast?

This episode is 10 minutes long.

When was this Ketamine Wellness Centers Podcast episode published?

This episode was published on March 20, 2019.

Can I download this Ketamine Wellness Centers Podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.